down arrow

Kewaunee Scientific Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4928541048
  • NASDAQ: KEQU
USD
34.03
-0.07 (-0.21%)

Sep 23

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Wrap Technologies, Inc.
Pro-Dex, Inc.
Milestone Scientific, Inc.
Kewaunee Scientific Corp.
Lucid Diagnostics, Inc.
Prenetics Global Ltd.
Rockwell Medical, Inc.
VolitionRX Ltd.
Cardiff Oncology, Inc.
HeartBeam, Inc.
Cue Health, Inc.

Why is Kewaunee Scientific Corp. ?

1
Negative results in Jul 26
  • ROCE(HY) Lowest at 11.59%
  • NET SALES(Q) Lowest at USD 66.32 MM
  • PRE-TAX PROFIT(Q) At USD 2.56 MM has Fallen at -25.44%
2
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 15.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -21.73% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kewaunee Scientific Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Kewaunee Scientific Corp.
-21.73%
-0.47
36.04%
S&P 500
15.76%
1.20
13.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
15.01%
EBIT Growth (5y)
70.17%
EBIT to Interest (avg)
2.99
Debt to EBITDA (avg)
0.57
Net Debt to Equity (avg)
0.39
Sales to Capital Employed (avg)
3.04
Tax Ratio
21.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
49.14%
ROCE (avg)
18.08%
ROE (avg)
11.29%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
1.39
EV to EBIT
5.73
EV to EBITDA
4.36
EV to Capital Employed
1.32
EV to Sales
0.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.02%
ROE (Latest)
16.58%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -0.6% (YoY

-11What is not working for the Company
ROCE(HY)

Lowest at 11.59%

NET SALES(Q)

Lowest at USD 66.32 MM

PRE-TAX PROFIT(Q)

At USD 2.56 MM has Fallen at -25.44%

NET PROFIT(Q)

At USD 1.71 MM has Fallen at -29.05%

Here's what is working for Kewaunee Scientific Corp.

Raw Material Cost
Fallen by -0.6% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Kewaunee Scientific Corp.

Net Sales
Lowest at USD 66.32 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (USD MM)

Pre-Tax Profit
At USD 2.56 MM has Fallen at -25.44%
over average net sales of the previous four periods of USD 3.43 MM
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
At USD 1.71 MM has Fallen at -29.05%
over average net sales of the previous four periods of USD 2.4 MM
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

Footer loading